Kolexia
Rabeau Audrey Pneumologie
Rabeau Audrey
Pneumologie
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, France
52 Activités
2 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules Mésothéliome Adénocarcinome pulmonaire Métastase tumorale Carcinome épidermoïde Bronchiolite Sarcomes

Collaborateurs

Voir plus
Mazieres Julien
Mazieres Julien
Hôpital Rangueil, Toulouse, France
Game Laurence
Game Laurence
Hôpital Larrey Toulouse, Toulouse, France
Audigier-Valette Clarisse
Audigier-Valette Clarisse
Centre Hospitalier Toulon, Toulon, France
Laborde Florian
Laborde Florian
Gcs Clinavenir, Toulouse, France

Industries

Voir plus
MSD
7 collaboration(s)
Dernière en 2023
BMS
5 collaboration(s)
Dernière en 2023
Sanofi
5 collaboration(s)
Dernière en 2023
VIATRIS MEDICAL
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer.
Frontiers in oncology   16 juin 2023
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50.
Cancer immunology, immunotherapy : CII   22 mai 2023
LUNG-RESIST: Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
Essai Clinique (CHU Toulouse)   11 mai 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.
Cancer discovery   04 avril 2023
RT-Immune: A European, Multicenter, Randomized, Open-label, Phase II Trial Aiming to Assess the Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy
Essai Clinique (Roche)   26 janvier 2023
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50.
Cancer immunology, immunotherapy : CII   24 janvier 2023
Stratégies et modalités des immunothérapies : espacement des doses, durée
Revue des maladies respiratoires actualites   01 octobre 2022
1113P Real-world multicentre cohort of 1L pembrolizumab alone or in combination with platinum-based chemotherapy in NSCLC PD-L1 ≥ 50%
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
EVIDENS: Lung Cancer Patients Treated With Nivolumab: A Longitudinal, Prospective, Observational, Multicentric Study
Essai Clinique (BMS)   18 mai 2022